Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

More articles from Neuropharmacology

  • You have access
    Persistent Spontaneous Oral Dyskinesias in Haloperidol-Withdrawn Rats Neonatally Lesioned with 6-Hydroxydopamine: Absence of an Association with the B max for [3H]Raclopride Binding to Neostriatal Homogenates
    Nuo-Yu Huang, Richard M. Kostrzewa, Chuanfu Li, Kenneth W. Perry and Ray W. Fuller
    Journal of Pharmacology and Experimental Therapeutics January 1997, 280 (1) 268-276;
  • You have access
    Inhibition of Lipopolysaccharide-Induced Nitric Oxide and Cytokine Production by Ultralow Concentrations of Dynorphins in Mixed Glia Cultures
    Ling-Yuan Kong, Michael K. McMillian, Pearlie M. Hudson, Lei Jin and Jau-Shyong Hong
    Journal of Pharmacology and Experimental Therapeutics January 1997, 280 (1) 61-66;
  • You have access
    N-Methyl-d-aspartate Antagonist Activity of α- and β-Sulfallorphans
    Vijay K. Shukla and Simon Lemaire
    Journal of Pharmacology and Experimental Therapeutics January 1997, 280 (1) 357-365;
  • You have access
    Psychopharmacological Profile of Amisulpride: An Antipsychotic Drug with Presynaptic D2/D3 Dopamine Receptor Antagonist Activity and Limbic Selectivity
    Gh. Perrault, R. Depoortere, E. Morel, D. J. Sanger and B. Scatton
    Journal of Pharmacology and Experimental Therapeutics January 1997, 280 (1) 73-82;
  • You have access
    Pharmacological Characterization of SIB-1765F: A Novel Cholinergic Ion Channel Agonist
    Aida I. Sacaan, Richard T. Reid, Emily M. Santori, Pamala Adams, Lucia D. Correa, Lorrence S. Mahaffy, Leo Bleicher, Nicholas D. P. Cosford, Kenneth A. Stauderman, Ian A. McDonald, Tadimeti S. Rao and G. Kenneth Lloyd
    Journal of Pharmacology and Experimental Therapeutics January 1997, 280 (1) 373-383;
  • You have access
    Neurochemical Characteristics of Amisulpride, an Atypical Dopamine D2/D3 Receptor Antagonist with Both Presynaptic and Limbic Selectivity
    H. Schoemaker, Y. Claustre, D. Fage, L. Rouquier, K. Chergui, O. Curet, A. Oblin, F. Gonon, C. Carter, J. Benavides and B. Scatton
    Journal of Pharmacology and Experimental Therapeutics January 1997, 280 (1) 83-97;
  • You have access
    Effects of a Novel Cholinergic Ion Channel Agonist SIB-1765F on Locomotor Activity in Rats
    Frédérique Menzaghi, Kevin T. Whelan, Victoria B. Risbrough, Tadimeti S. Rao and G. Kenneth Lloyd
    Journal of Pharmacology and Experimental Therapeutics January 1997, 280 (1) 384-392;
  • You have access
    Interactions between a Novel Cholinergic Ion Channel Agonist, SIB-1765F and L-DOPA in the Reserpine Model of Parkinson’s Disease in Rats
    Frédérique Menzaghi, Kevin T. Whelan, Victoria B. Risbrough, Tadimeti S. Rao and G. Kenneth Lloyd
    Journal of Pharmacology and Experimental Therapeutics January 1997, 280 (1) 393-401;
  • You have access
    Blood-Brain Barrier Permeability and Bioavailability of a Highly Potent and μ-Selective Opioid Receptor Antagonist, CTAP: Comparison with Morphine
    Thomas J. Abbruscato, Sarah A. Thomas, Victor J. Hruby and Thomas P. Davis
    Journal of Pharmacology and Experimental Therapeutics January 1997, 280 (1) 402-409;
  • You have access
    Decreases in Evoked Overflow of Dopamine in Rat Striatum after Neurotoxic Doses of Methamphetamine
    Wayne A. Cass
    Journal of Pharmacology and Experimental Therapeutics January 1997, 280 (1) 105-113;

Pages

  • Previous
  • Next
  • 1
  • …
  • 209
  • 210
  • 211
  • 212
  • 213
  • 214
  • 215
  • 216
  • 217
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2019 by the American Society for Pharmacology and Experimental Therapeutics